Thats understandable, but it misses the bigger issue
These include temporary redness, mild swelling, occasional bruising, and slight burning sensation during administration
Inanmdar W, Sultana A, Mubeen U, Rahman K
Furthermore, tranilast has been investigated in Phase II clinical trials in combination with allopurinol for patients experiencing moderate-to-severe gouty arthritis
If compounding access is restored for these substances, they will still not be FDA-approved drugs
And safer is an unearned claim the absence of long-term controlled safety data means safety is unknown, not established